Hematologist/oncologist and assistant professor in the Department of Internal Medicine, Division of Hematology and Oncology at the University of Arkansas for Medical Sciences.
Quadruplets Seen as Top Option in Transplant-Ineligible Multiple Myeloma Due to Efficacy
Samer A. Al'Hadidi, MD, MS, discusses the response and survival of 2 quadruplet therapy trials for patients with transplant-ineligible multiple myeloma.